# Salmonella Testing Market

> Salmonella Testing Market Research Report By Methodology (Polymerase Chain Reaction, Enzyme-Linked Immunosorbent Assay, Culture Method, Rapid Testing Kits), By Sample Type (Food Samples, Water Samples, Environmental Samples, Clinical Samples), By End Use (Food Industry, Pharmaceutical Industry, Environmental Testing, Clinical Diagnostics), By Technology (Molecular Diagnostics, Traditional Microbiological Methods, Immunological Testing, Nucleic Acid Testing) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2026-2035
- **CAGR:** 7.95%
- **2025:** USD 3.68 Billion
- **2035:** USD 7.91 Billion
- **Key Players:** bioMérieux SA, Thermo Fisher Scientific, Neogen Corporation, Merck KGaA, Eurofins Scientific, Bio-Rad Laboratories, Mérieux NutriSciences, SGS SA

**Report ID:** MRFR/HC/37022-HCR · **Pages:** 100 · **Author:** Nidhi Mandole & Rahul Gotadki · **Last Updated:** September 17, 2026

**URL:** https://www.marketresearchfuture.com/reports/salmonella-testing-market-39010

---

## Market Summary

## Salmonella Testing Market Summary

The Salmonella Testing Market reached USD 3.68 billion in 2025 and opens the forecast window at USD 3.97 billion in 2026, climbing to USD 7.91 billion by 2035 at a 7.95% CAGR. Two catalysts anchor that trajectory. The first is the U.S. Food Safety Modernization Act Section 204 traceability rule, whose enforcement date pushed processors of poultry, produce, and ready-to-eat foods into documented lot-level pathogen verification [1]. The second is the USDA Food Safety and Inspection Service reorganisation of poultry performance standards, which raised verification sampling frequency at roughly 5,900 federally inspected establishments [2].

Laboratory workflows are changing faster than volumes alone suggest. Selective enrichment followed by 48-hour plate confirmation still underpins regulatory sign-off, but it is steadily giving ground to real-time PCR, loop-mediated isothermal amplification and whole-genome sequencing running on automated liquid-handling decks. bioMérieux committed roughly EUR 220 million to molecular food-safety capacity between 2023 and 2025, and Mérieux NutriSciences closed a EUR 360 million purchase of Bureau Veritas' food-testing division, adding 34 laboratories in a single transaction [3][4]. Result windows have compressed from two days to under 30 minutes on point-of-need systems.

Geographically, North America holds 34.1% of the Salmonella Testing Market on the strength of FSMA and FSIS enforcement. Asia-Pacific expands quickest at a 10.12% CAGR as China, Australia, and ASEAN states stand up genomic-surveillance networks that consume far higher test volumes. Europe follows North America at 27.6%, supported by EFSA zoonoses reporting obligations and retailer certification schemes. Through 2035, the Salmonella Testing Market will reward suppliers that pair validated chemistry with data infrastructure rather than assay speed alone.

## Key Report Takeaways

### • By Offering

- Test kits and reagents held 59.8% of Salmonella Testing Market revenue in 2025, reflecting entrenched consumable-led purchasing
- Services are the fastest-expanding offering at a 10.44% CAGR through 2035

### • By Test Type

- PCR-based methods captured 34.9% of the Salmonella Testing Market in 2025
- Isothermal amplification advances at an 11.32% CAGR, the highest of any method class

### • By Sample Type

- Food matrices accounted for 41.6% of tested volume value in 2025
- Feed and pet food posts a 12.35% CAGR, the steepest sample-type trajectory

### • By End-User

- Food and beverage manufacturers represented 31.1% of demand in 2025
- Contract laboratories grow at a 10.18% CAGR as complexity migrates outward

### • By Region

- North America commanded 34.1% share in 2025
- Asia-Pacific records a 10.12% CAGR to 2035
- Europe generated USD 1.02 billion in 2025

## Market Size and Forecast (2021–2035)

Historical values were reconstructed from consumable shipment data, accredited laboratory throughput filings, and public-sector sampling volumes published by USDA FSIS, EFSA, and equivalent national agencies. Forecast values apply a bottom-up build of installed instrument base, per-instrument annual reagent consumption, and outsourced service contract value, then reconcile against top-down revenue disclosures from listed diagnostics suppliers. All figures are expressed in USD Billion at constant 2025 exchange rates.

## Market Drivers

## Driver Impact Analysis

| Driver | ~% Impact on CAGR | Geographic Relevance | Impact Timeline | Ref |
| --- | --- | --- | --- | --- |
| FSMA 204 traceability enforcement | ~1.9% | North America | Short-term (≤2 yr) | [1] |
| Feed and pet food sampling mandates | ~1.6% | Global | Medium-term (2–4 yr) | [7] |
| Migration to rapid molecular platforms | ~1.4% | Global | Medium-term (2–4 yr) | [3] |
| Asia-Pacific genomic surveillance networks | ~1.2% | Asia-Pacific | Long-term (≥4 yr) | [8] |
| Outsourcing to contract laboratories | ~1.0% | North America, Europe | Medium-term (2–4 yr) | [4] |
| Alternative protein manufacturing growth | ~0.7% | Europe, North America | Long-term (≥4 yr) | [9] |
| Retailer certification schemes | ~0.6% | Global | Short-term (≤2 yr) | [10] |

### FSMA 204 Traceability Enforcement

Pathogen verification records are at the core of the paperwork required by the FDA's Food Traceability Final Rule, which requires companies handling specified high-risk foods to keep essential data items at crucial tracking events. The FDA predicted that around 89,000 covered firms will incur first-year industry compliance costs of close to USD 570 million [1]. In response, processors switched from composite sampling to lot-discrete testing, which resulted in an estimated 22% increase in annual assay counts in mid-size chicken operations.

### Feed and Pet Food Sampling Mandates

A chemical safety net was eliminated by post-antibiotic feed techniques, necessitating quantitative load tracking from raw ingredient consumption through pellet completion. Up to 96% of production lots are currently tested by rendered-protein providers as a result of the USDA and EU Regulation 2019/4 tightening requirements on feed hygiene verification [7]. Poultry integrators received load-level rather than presence-absence data from Neogen's quantitative MDA2 technology, which transformed a compliance line item into an intervention-efficacy indicator worth recurring investment.

### Migration to Rapid Molecular Platforms

Legacy culture confirmation ties finished goods in warehouses for two days, and every held day carries working-capital cost. Real-time PCR and multiplex isothermal panels cut that to hours, and bioMérieux reported 13% reagent sales growth in H1 2024 on the back of closed-system adoption [3]. Plants converting from culture-first workflows typically report product-release cycles shortening by 30 to 36 hours, which funds the instrument inside two years.

### Asia-Pacific Genomic Surveillance Networks

China's National Foodborne Disease Surveillance Network and Australia's OzFoodNet expanded sequencing-backed source attribution across additional sentinel sites between 2023 and 2025, with combined public allocations exceeding USD 140 million [8]. Surveillance of this kind requires isolate volumes far above routine release testing, and it pulls commercial laboratories into government tender work. Regional demand for foodborne pathogen detection capacity consequently outpaces the global average by roughly two percentage points annually.

### Outsourcing to Contract Laboratories

Whole-genome SNP comparison, in-silico serotyping andresistome mapping demand bioinformatics staff that most processors will nothire. A major food-testing provider's EUR 360 million acquisition of a food-testingarm added 34 laboratories and signalled how quickly network scale is beingassembled [4]. Multinational manufacturers increasingly centralise protocols witha single provider, converting scattered plant-level spend into managed contractsworth USD 2–6 million per account annually.

### Alternative Protein Manufacturing Growth

Plant-based and precision-fermentation matrices behave differently under enrichment, with high fat and hydrocolloid content suppressing recovery. FDA and EFSA validation reviews for these matrices remain open, so manufacturers run parallel method streams to protect release decisions [9]. European plant-protein capacity additions exceeding EUR 1.1 billion between 2023 and 2025 therefore generate disproportionate assay demand per tonne relative to conventional meat processing.

### Retailer Certification Schemes

Global Food Safety Initiative benchmarked schemes — BRCGS, SQF and FSSC 22000 — now cover more than 180,000 certified sites, and each audit cycle requires documented environmental and finished-product pathogen data [10]. Private buyer requirements frequently exceed statutory minimums, particularly for ready-to-eat categories. Suppliers that fail an unannounced audit face delisting, which makes testing spend closer to a commercial necessity than a regulatory cost.

## Restraints

## Restraints Impact Analysis

| Restraint | ~% Impact on CAGR | Geographic Relevance | Impact Timeline | Ref |
| --- | --- | --- | --- | --- |
| High per-test cost for small processors | ~-1.1% | Global | Short-term (≤2 yr) | [11] |
| Shortage of trained microbiologists | ~-0.9% | Asia-Pacific, MEA, South America | Long-term (≥4 yr) | [12] |
| False positives in complex matrices | ~-0.7% | Global | Medium-term (2–4 yr) | [9] |
| Method validation and approval lag | ~-0.6% | Europe, North America | Medium-term (2–4 yr) | [13] |
| Fragmented laboratory data standards | ~-0.4% | Global | Long-term (≥4 yr) | [14] |

### High Per-Test Cost for Small Processors

Before instrument amortization, rapid molecular tests usually cost between USD 9 and USD 18 per reaction, compared to USD 3 to USD 5 for traditional culture consumables [11]. That difference determines purchases for businesses with less than $25 million in revenue. Unit conversion is limited in precisely the fragmented section that regulators most want to modernize because many continue to use culture procedures and absorb greater hold times.

### Shortage of Trained Microbiologists

In Southeast Asia, Sub-Saharan Africa, and portions of South America, the growth of accredited laboratories is limited by personnel rather than funding. Most country food laboratories evaluated had qualified-personnel deficits, according to WHO capacity assessments [12]. Qualified analysts frequently experience six- to nine-month vacancy intervals, and instruments that are inactive due to a lack of operators result in realized reagent pull-through that is far below vendor expectations.

### False Positives in Complex Matrices

Spices, cocoa, high-fat dairy, and hydrocolloid-rich plant proteins produce inhibitory backgrounds that generate presumptive positives requiring culture confirmation anyway [9]. Each false positive triggers product holds costing mid-size manufacturers USD 40,000 to USD 120,000 per event. That risk keeps quality managers conservative about method switches and slows displacement of confirmatory culture from release protocols.

### Method Validation and Approval Lag

AOAC Performance Tested and ISO 16140-2 validations run 9 to 18 months per matrix claim, and regulators rarely accept extrapolation across dissimilar food categories [13]. Vendors therefore launch with narrow claims and widen slowly. Buyers operating diverse product portfolios are left running multiple validated methods in parallel, which raises training burden and dilutes the efficiency case for consolidation.

### Fragmented Laboratory Data Standards

Rapid platforms commonly export proprietary result formats, and few interoperate cleanly with plant-level LIMS or ERP quality modules without middleware [14]. Integration projects consume 8 to 12 weeks of IT effort per instrument line. The resulting manual transcription undermines the traceability benefit that justified the purchase, and it delays multi-site rollouts at exactly the accounts with the largest volume potential.

## Opportunities

## Salmonella Testing Market Opportunities

### Point-of-Need Detection at the Production Line

Battery-powered isothermal readers and cartridge-based systems move screening from the central laboratory to the line, and start-ups have demonstrated actionable results in under 30 minutes. Processors that intercept contamination before packaging avoid downstream recall exposure entirely, a category where FDA recorded average per-event costs above USD 10 million for mid-size firms [1]. Suppliers able to deliver validated on-site chemistry with cloud result capture will capture a disproportionate share of new instrument placements.

### Emerging-Market Laboratory Network Expansion

India's FSSAI notified laboratory network, Brazil's MAPA accreditation programme and ASEAN mutual-recognition work are all creating accredited capacity where little existed. World Bank food-safety lending to low- and middle-income countries exceeded USD 480 million across 2023–2025 [15]. Vendors that pair mid-tier instruments with local training and financing — rather than exporting flagship platforms — will convert this capacity into durable reagent annuities.

### Data Monetisation Through Sequencing-as-a-Service

Whole-genome sequencing generates value beyond a pass-fail result: serovar attribution, persistence mapping across a facility, and resistance prediction. Contract laboratories now package this as tiered subscriptions priced at two to three times routine confirmation, with analytics dashboards raising switching costs meaningfully [4]. Recurring analytics revenue carries software-like margins and reframes the vendor relationship from consumable supplier to quality partner.

### Water, Environmental and One Health Scope Expansion

Zone-based environmental swabbing is expanding faster than finished-product testing, because regulators and auditors increasingly treat facility hygiene data as the leading indicator of process control. Irrigation water testing under FSMA's agricultural water provisions adds a further tranche of demand across produce growing regions [1]. This widening scope pulls the Salmonella Testing Market beyond processing plants into farm, watershed and veterinary settings.

### Validated Chemistry for Alternative Protein Matrices

No supplier currently holds broad validated claims across textured plant protein, mycoprotein and precision-fermentation dairy analogues. The first vendor to secure ISO 16140-2 equivalence across that matrix set gains a defensible position with a manufacturer cohort adding capacity quickly and lacking legacy method loyalty [9]. Early claim ownership here tends to persist, since revalidation costs discourage switching once a plant qualifies a method.

## Future Outlook

## Salmonella Testing Market Future Outlook

### Automation and Machine Learning in Result Interpretation

Automated liquid handling now covers enrichment transfer, extraction, and plate setup on high-throughput lines, cutting hands-on time per sample by roughly 60%. Layered on top, machine-learning classifiers interpret amplification curves and flag matrix inhibition before a technician sees the run, reducing repeat testing. Vendors are moving toward closed ecosystems where instrument, reagent and interpretation software ship together, which lifts realised revenue per placement while making method switching materially harder for the buyer [3].

### Whole-Genome Sequencing at Routine Scale

Sequencing cost per bacterial isolate has fallen below USD 40 on high-density flow cells, and that threshold changes what regulators can reasonably require. GenomeTrakr and comparable networks have already demonstrated that isolate-level relatedness resolves outbreak attribution faster than serotyping [17]. Expect confirmation workflows to add a sequencing step by the early 2030s, with source-tracking and persistence mapping becoming standard deliverables rather than premium investigations reserved for post-incident forensics.

### Subscription and Platform Economics

Reagent-plus-instrument selling is giving way to contracts bundling consumables, service, analytics dashboards, and audit-ready reporting into per-sample or per-site subscriptions. This smooths supplier revenue and shifts buyer conversations from unit price to cost per released lot. Contract laboratories are following the same logic, packaging tiered analytics above baseline confirmation [4]. Suppliers without a credible software layer will find themselves competing on consumable price alone, which is the weakest position in the Salmonella Testing Market.

### One Health Integration and Supply-Chain Disclosure

Regulators and large buyers increasingly want pathogen data linked across farm, feed, processing and clinical settings rather than siloed by jurisdiction. FAO and WHO One Health guidance has pushed national programmes toward shared isolate repositories [12]. Parallel pressure comes from ESG reporting frameworks, where food-safety incident rates now appear in supplier scorecards at several major retailers. Testing data is consequently becoming a disclosed performance metric, which raises both volume and documentation requirements.

## Segment Insights

## Salmonella Testing Market Segmentation

### By Offering

| Segment | Metric (2025) | Primary Demand Driver |
| --- | --- | --- |
| Instruments & Automation Platforms | USD 0.90 Billion | Throughput consolidation and closed-system adoption |
| Test Kits & Reagents | 59.8% share | Recurring per-lot verification requirements |
| Services | 10.44% CAGR | Outsourced sequencing and bioinformatics workloads |

Consumables anchor the Salmonella Testing Market because every released lot consumes reagent regardless of instrument vintage, and installed-base inertia protects that revenue. Services grow fastest for the opposite reason: sequencing, in-silico serotyping, and resistance profiling require bioinformatics staff that processors decline to hire. Instruments and automation platforms grow moderately, since a single automated deck replaces several manual benches and suppresses unit count even as revenue per placement rises.

### By Test Type

| Segment | Metric (2025) | Primary Demand Driver |
| --- | --- | --- |
| Conventional Culture Methods | USD 0.97 Billion | Regulatory confirmation and dispute resolution |
| Immunoassay | 7.10% CAGR | Low-cost screening in resource-constrained laboratories |
| PCR-Based | 34.9% share | Validated speed with broad matrix claims |
| Isothermal | 11.32% CAGR | Battery-operable, low-capital field deployment |
| Next-Generation Sequencing | USD 0.27 Billion | Source attribution and resistance surveillance |

PCR leads on validation depth and installed base, and its matrix claim library remains unmatched. Isothermal methods, chiefly LAMP, grow fastest because they run on simple heaters, which suits on-farm and border-inspection work where capital budgets are thin. Conventional culture is not disappearing; it retains its role in regulatory confirmation and remains the reference against which alternatives are validated. Sequencing adds an analytical layer rather than displacing any existing method.

### By Sample Type

| Segment | Metric (2025) | Primary Demand Driver |
| --- | --- | --- |
| Food | 41.6% share | Finished-product release testing across meat, dairy and produce |
| Feed & Pet Food | 12.35% CAGR | Post-antibiotic quantitative load tracking |
| Environmental Samples | USD 0.53 Billion | Zone-based swabbing within HACCP plans |
| Clinical & Veterinary Samples | 9.60% CAGR | Zoonotic surveillance and herd health programmes |
| Water & Beverage | 6.4% share | Agricultural water provisions and process water controls |

Food matrices dominate the Salmonella Testing Market by volume because release testing applies to essentially every regulated lot. Feed and pet food accelerate fastest as antibiotic-free production strategies remove a suppression mechanism and require quantitative rather than presence-absence monitoring from raw ingredient through finished pellet. Environmental swabbing expands steadily inside HACCP programmes, where auditors increasingly weight facility hygiene data above finished-product results as a control indicator.

### By End-User

| Segment | Metric (2025) | Primary Demand Driver |
| --- | --- | --- |
| Food & Beverage Manufacturers | 31.1% share | In-house QA workflows tied to release decisions |
| Contract Laboratories | 10.18% CAGR | Absorption of analytics-heavy testing workloads |
| Government & Regulatory Agencies | USD 0.62 Billion | Statutory verification sampling and surveillance |
| Research & Academic Institutes | 8.50% CAGR | Method development and outbreak forensics |
| Others | 6.2% share | Retailers, food service groups and certification bodies |

Manufacturers hold the largest end-user position in the Salmonella Testing Market because release decisions cannot wait on third-party turnaround. Contract laboratories nonetheless grow fastest, taking on whole-genome SNP comparison and resistome mapping that no single plant can staff. Government agencies provide a stable revenue floor tied to statutory sampling rather than commercial cycles, while academic institutes influence the market indirectly by publishing the validations that commercial buyers subsequently demand.

## Regional Market Share Analysis

## Regional Market Share Analysis

| Region | Metric (2025) | Primary Investment Themes |
| --- | --- | --- |
| North America | 34.1% share | FSMA 204 compliance, automation retrofits, contract laboratory consolidation |
| Europe | USD 1.02 Billion | EFSA zoonoses reporting, retailer certification, plant-protein matrix validation |
| Asia-Pacific | 10.12% CAGR | Genomic surveillance networks, accredited capacity build-out, export certification |
| South America | USD 0.29 Billion | Poultry and beef export certification, feed hygiene programmes |
| Middle East & Africa | 5.6% share | Import inspection infrastructure, national reference laboratory upgrades |
| Total | USD 3.68 Billion | — |

Regional performance in the Salmonella Testing Market tracks enforcement intensity more closely than population or food output. Mature regulatory regimes generate steady, high-frequency verification testing, while emerging surveillance programmes drive faster percentage growth from smaller bases.

### North America

| Country | Metric | Key Driver |
| --- | --- | --- |
| US | 78.4% of region | FSMA 204 traceability and FSIS performance standards |
| Canada | USD 0.16 Billion | Safe Food for Canadians Regulations preventive control plans |
| Mexico | 9.60% CAGR | Export certification for poultry and fresh produce |

Enforcement density explains North American leadership. FSIS conducts verification sampling across roughly 5,900 federally inspected establishments, and its raw poultry performance standards tie continued operation to demonstrated pathogen control [2]. Canada's SFCR pushed preventive control plans into establishments previously outside federal registration, widening the buyer base rather than deepening spend per site. Mexico's growth is export-led: Senasica certification requirements for shipments into the United States and Asia have driven private laboratory investment in Jalisco, Sonora and Querétaro, where poultry and berry exporters concentrate.

### Europe

| Country | Metric | Key Driver |
| --- | --- | --- |
| Germany | 21.8% of region | Large meat processing base and BRCGS certification density |
| UK | USD 0.15 Billion | FSA sampling programmes and retailer specification testing |
| France | 17.4% of region | Poultry sector surveillance and export verification |
| Italy | 8.20% CAGR | Regional laboratory modernisation and charcuterie sector controls |
| Spain | USD 0.09 Billion | Pork export volumes and feed hygiene enforcement |
| Nordic Countries | 7.9% of region | Salmonella-free status maintenance programmes |
| Russia | 5.60% CAGR | Domestic poultry expansion and import substitution |
| Rest of Europe | USD 0.11 Billion | Accession-driven laboratory accreditation |

European demand rests on a reporting obligation rather than a testing mandate alone. EFSA and ECDC's annual zoonoses report compels member states to submit isolate-level data, which sustains public laboratory volumes independent of commercial cycles [6]. Nordic states occupy an unusual position: national control programmes maintain near-zero prevalence, and preserving that status requires continuous high-frequency screening despite low positivity. Germany's share reflects processing concentration, while Italy's faster growth comes from regional public laboratory consolidation replacing manual culture benches with automated molecular lines.

### Asia-Pacific

| Country | Metric | Key Driver |
| --- | --- | --- |
| China | 33.6% of region | National Foodborne Disease Surveillance Network expansion |
| India | 12.85% CAGR | FSSAI notified laboratory network and export compliance |
| Japan | USD 0.14 Billion | HACCP obligation under the Food Sanitation Act |
| South Korea | 9.2% of region | MFDS import inspection and retail surveillance |
| ASEAN | 11.90% CAGR | Mutual recognition arrangements and aquaculture export testing |
| Rest of Asia-Pacific | USD 0.08 Billion | Australian and New Zealand genomic source attribution |

Asia-Pacific growth is a capacity story rather than a substitution story. China's surveillance network extended sequencing-backed source attribution to additional sentinel provinces between 2023 and 2025, and isolate characterisation of that kind consumes far more laboratory hours than routine release screening [8]. India's expansion follows FSSAI's push to notify and accredit private laboratories, opening testing to processors that previously self-certified. ASEAN aquaculture exporters face buyer-imposed testing that exceeds domestic law, and Australia's OzFoodNet integration of clinical and food isolates has made whole-genome sequencing routine for outbreak forensics.

### South America

| Country | Metric | Key Driver |
| --- | --- | --- |
| Brazil | 61.5% of region | Poultry export certification under MAPA programmes |
| Argentina | USD 0.05 Billion | Beef export verification and Senasa sampling |
| Rest of South America | 8.70% CAGR | Aquaculture and fruit export compliance |

Brazil dominates because export destinations dictate its testing regime. Poultry shipments to the European Union, Japan and Saudi Arabia each carry distinct sampling specifications, and MAPA-registered establishments run parallel protocols to satisfy them [15]. Argentina's demand concentrates in beef, where Senasa verification underpins Hilton quota access. Elsewhere, Chilean salmon and Peruvian fruit exporters have driven accredited private laboratory openings in Puerto Montt and Lima, though scale remains modest relative to Brazil's processing footprint.

### Middle East & Africa

| Country | Metric | Key Driver |
| --- | --- | --- |
| Saudi Arabia | 27.4% of region | SFDA import inspection and domestic poultry investment |
| UAE | 10.40% CAGR | Dubai Municipality food control and re-export hub testing |
| South Africa | USD 0.05 Billion | Poultry sector controls and national reference laboratory capacity |
| Egypt | 14.2% of region | Import screening and domestic processing expansion |
| Rest of MEA | 9.30% CAGR | Donor-funded laboratory accreditation programmes |

Import dependence shapes this region's profile. Saudi Arabia's SFDA applies border screening to high-risk consignments while simultaneously funding domestic poultry self-sufficiency targets, generating demand at both ends of the chain [16]. The UAE's position as a re-export hub means consignments are frequently tested twice, once on arrival and again before onward shipment. South Africa's capacity concentrates in Gauteng and the Western Cape, and donor-funded accreditation work under WHO and FAO programmes is slowly extending accredited coverage into East and West Africa.

## Competitive Benchmarking

## Competitive Benchmarking

Concentration sits in the medium band, with an estimated HHI between 900 and 1,150 and a top-five combined share near 44%. That leaves a long tail of regional kit manufacturers and independent laboratories competing on price and turnaround. Consolidation is active on the services side, where network scale determines multinational account eligibility, while the reagent side stays defended by validation portfolios that take years and considerable expense to replicate.

| Company | Est. Revenue Share Range | Key Offerings for Salmonella Testing Market | Strategic Positioning |
| --- | --- | --- | --- |
| bioMérieux SA | ~12–15% | GENE-UP PCR, VIDAS immunoassay, culture media | Closed-ecosystem leader with deep validation library |
| Thermo Fisher Scientific | ~9–12% | SureTect real-time PCR, Oxoid media, sequencing platforms | Broadest portfolio spanning screening to sequencing |
| Neogen Corporation | ~8–11% | ANSR isothermal, Reveal lateral flow, MDA2 quantitative | Strong feed and protein-sector penetration |
| Merck KGaA | ~5–7% | Selective media, enrichment broths, Assurance GDS | Culture chemistry depth with global distribution |
| Eurofins Scientific | ~5–7% | Accredited testing services, sequencing, consulting | Largest independent food-testing laboratory network |
| Bio-Rad Laboratories | ~4–6% | iQ-Check PCR, RAPID chromogenic media | Molecular specialist with strong European base |
| Mérieux NutriSciences | ~4–6% | Contract testing, environmental monitoring programmes | Aggressive acquirer building global laboratory density |
| SGS SA | ~3–5% | Third-party certification and pathogen testing | Certification-linked testing across export corridors |
| QIAGEN NV | ~3–4% | Extraction chemistries, microbial DNA workflows | Upstream sample-preparation specialist |
| Hygiena LLC | ~2–4% | BAX System PCR, environmental monitoring tools | Rapid-result focus with plant-floor deployment |
| Bureau Veritas | ~2–3% | Inspection and laboratory testing services | Trade-compliance orientation post-divestment |

## Recent News & Developments

## Recent News & Developments

- Neogen Corporation (March 2023): Launched the MDA2 quantitative platform for feed and poultry matrices, shifting customers from presence-absence screening to intervention-efficacy measurement [7].
- FDA (January 2024): Confirmed the compliance framework for the Food Traceability Final Rule covering listed high-risk foods, formalising documentation obligations that anchor verification testing programmes [1].
- bioMérieux (July 2024): Reported 13% first-half reagent sales growth in food safety, attributing gains to closed-system molecular adoption among large processors [3].
- Mérieux NutriSciences (July 2024): Completed the EUR 360 million acquisition of Bureau Veritas' food-testing division, adding 34 laboratories and reshaping service-side scale [4].
- EFSA and ECDC (December 2024): Published the annual EU One Health zoonoses report, reiterating salmonellosis as a leading reported foodborne infection and reinforcing member-state isolate reporting [6].
- USDA FSIS (February 2025): Advanced revised poultry performance standards linking establishment status to demonstrated pathogen control, raising verification sampling expectations [2].
- Thermo Fisher Scientific (June 2025): Expanded SureTect matrix claims into plant-based protein categories, addressing a validation gap flagged by alternative protein manufacturers [9].
- FSSAI (September 2025): Widened its notified laboratory network for food pathogen testing, extending accredited capacity to additional states and export clusters [18].

## Report Scope

| Parameter | Detail |
| --- | --- |
| Market Scope | Global market for instruments, consumables and services used to detect and characterise Salmonella across food, feed, environmental, water and clinical veterinary samples |
| Study Period | 2021–2035 (Historical 2021–2024; Base Year 2025; Forecast 2026–2035) |
| CAGR | 7.95% (2026–2035) |
| Market Size Checkpoints | USD 3.68 Billion (2025); USD 3.97 Billion (2026); USD 5.40 Billion (2030); USD 7.91 Billion (2035) |
| Fastest Growing Segments | Services (10.44% CAGR); Isothermal (11.32% CAGR); Feed & Pet Food (12.35% CAGR); Contract Laboratories (10.18% CAGR); Asia-Pacific (10.12% CAGR) |
| Companies Profiled | bioMérieux, Thermo Fisher Scientific, Neogen, Merck KGaA, Eurofins Scientific, Bio-Rad Laboratories, Mérieux NutriSciences, SGS, QIAGEN, Hygiena, Bureau Veritas |
| Valuation Currency | USD Billion, constant 2025 exchange rates |

## Frequently Asked Questions

**Q: What should a procurement team prioritise when selecting a vendor in the Salmonella Testing Market?**
A: Weight matrix-specific validation status and reagent supply continuity above unit price. Certifications covering your exact product categories cut re-validation cost, which frequently exceeds three years of consumable savings [13].

**Q: How does isothermal amplification compare with PCR on total cost of ownership?**
A: Isothermal platforms lower capital outlay by roughly 40% because they avoid precision thermal cyclers, though per-test reagent pricing runs higher. Facilities below 200 tests weekly usually favour isothermal; higher-throughput plants recover PCR instrument cost within two years [11].

**Q: What integration challenges slow adoption across the Salmonella Testing Market?**
A: LIMS connectivity is the main bottleneck, since many rapid platforms export proprietary result formats requiring middleware. Plants running mixed vendor fleets typically budget 8 to 12 weeks of IT work per instrument line [14].

**Q: Does laboratory accreditation status affect buyer audit outcomes?**
A: Yes. ISO/IEC 17025-accredited results are accepted without re-testing by most major retailers, which shortens audit cycles measurably. Processors lacking accreditation often absorb duplicate testing costs during third-party certification [14].

**Q: How are suppliers responding to microbiologist shortages?**
A: Vendors now ship pre-filled, room-temperature-stable cartridges requiring under five minutes of hands-on time, letting line technicians run assays without microbiology degrees. Several bundle remote scientific support into reagent contracts [12].

**Q: What role will environmental monitoring play in the Salmonella Testing Market?**
A: Zone-based swabbing programmes are expanding faster than finished-product testing because auditors treat facility hygiene data as the leading control indicator. Swab volumes per plant are expected to roughly double by 2030 [10].

**Q: Is antimicrobial resistance profiling becoming a routine add-on?**
A: Resistance profiling is moving from research use into routine surveillance, particularly across poultry and swine supply chains. Contract laboratories sell it as a tiered upgrade to standard confirmation, typically at two to three times the base price [17].


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/salmonella-testing-market-39010*